Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration

Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration

Abstract Objectives To evaluate the outcomes of delayed intravitreal injections (IVIs) caused by the outbreak of coronavirus disease 2019 (COVID-19), in patients with neovascular age-related macular degeneration (nAMD). Methods nAMD patients with scheduled IVIs between March 1st and April 30th, 2020...

Full description

Bibliographic Details
Main Authors: Marco Nassisi, Francesco Pozzo Giuffrida, Paolo Milella, Simone Ganci, Andrea Aretti, Claudia Mainetti, Laura Dell’Arti, Chiara Mapelli, Francesco Viola
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Ophthalmology
Subjects:
Anti-VEGF
Neovascular age-related macular degeneration
Intravitreal injections
COVID-19
Online Access:https://doi.org/10.1186/s12886-023-02864-x

Internet

https://doi.org/10.1186/s12886-023-02864-x

Similar Items